1510. Deputy Shane Moynihan asked the Minister for Health the measures being taken to improve the availability and supply of Creon (pancreatic enzymes) to Ireland. [10766/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
1665. Deputy Seán Ó Fearghaíl asked the Minister for Health the reason for the shortage of certain medicines (details supplied); and if she will make a statement on the matter. [11508/25]
1690. Deputy John Brady asked the Minister for Health if consideration will be given to implementing a reimbursement scheme through the medical card and or drugs payment scheme for Ozempic; and if she will make a statement on the matter. [11650/25]
1755. Deputy Marie Sherlock asked the Minister for Health if durvalumab is being considered for use by the HSE as part of the first-line treatment of patients with cholangiocarcinoma (bile duct cancer) as is now the case in the United Kingdom; and if she will make a statement on the matter. [11901/25]
1866. Deputy Grace Boland asked the Minister for Health when she intends to launch the review into Ireland's reimbursement process; and if she will make a statement on the matter. [12554/25]
1869. Deputy Grace Boland asked the Minister for Health if she intends to review how orphan medicinal products are assessed and reimbursed as part of the Programme for Government's commitment to conduct a review into Ireland's reimbursement process; and if she will make a statement on the matter. [12557/25]
1870. Deputy Grace Boland asked the Minister for Health if the upcoming Rare Disease Strategy will provide recommendations/actions on how to improve Ireland's reimbursement process for innovative treatments for rare disease patients; and if she will make a statement on the matter. [12558/25]
1871. Deputy Grace Boland asked the Minister for Health the steps she will take to implement the Programme for Government's commitment to introduce early access/interim access schemes for patients who require urgent access to EMA-approved treatments in advance of a decision to reimburse the treatment in Ireland; and if she will make a statement on the matter. [12559/25]
119. Deputy Peter Roche asked the Minister for Health the measures being taken to address the rising costs of prescription medicines in Ireland; if she has considered introducing additional supports or subsidies to alleviate the financial burden on patients; the steps being implemented to improve the availability of essential medicines; if a more sustainable model will be introduced; and if she will make a statement …
166. Deputy Aindrias Moynihan asked the Minister for Health the up-to-date position on a medication (details supplied) to be made available through the drugs payment scheme; and if she will make a statement on the matter. [10121/25]
162. Deputy David Cullinane asked the Minister for Health to provide an update on the funded HRT scheme announced in Budget 2025; what discussions her officials have had with the Irish Pharmacy Union in relation to the scheme; and if she will make a statement on the matter. [9853/25]
163. Deputy David Cullinane asked the Minister for Health if she will provide an update on whether injectable semaglutide medicines will be made available to obesity patients on the drugs payment scheme before the end of the year; and if she will make a statement on the matter. [9854/25]
164. Deputy David Cullinane asked the Minister for Health if she is aware of the ongoing shortage of prescription packs (60 tablets) of soluble Solpadine, not to be confused with the over-the-counter packs available without prescription available in 12 and 24 tablets; if officials from her Department have discussed the shortage with the HPRA or manufacturer; and if she will make a statement on the matter. [9855/25]
165. Deputy David Cullinane asked the Minister for Health to provide an update on the timeline for the introduction of pharmacist prescribing; what recommendations from the expert taskforce have been achieved so far; and if she will make a statement on the matter. [9857/25]
185. Deputy Colm Burke asked the Minister for Health if she will consider reducing the threshold of the drugs payment scheme to €72 per month, as per the 2017 Sláintecare report; and if she will make a statement on the matter. [9954/25]
194. Deputy Ryan O'Meara asked the Minister for Health for an update on the rollout of the hormone replacement therapy programme, with specific regard to the ongoing discussions regarding dispensing fees; and if she will make a statement on the matter. [10023/25]
707. Deputy James Geoghegan asked the Minister for Health if the 34 new whole-time equivalent positions for the agencies involved in the HSE’s medicines pricing and reimbursement system, as initially prescribed in February 2023, have now been successfully filled; whether they have commenced their engagement; and if she will make a statement on the matter. [9516/25]
713. Deputy Catherine Connolly asked the Minister for Health further to Parliamentary Question No. 1086 of 5 February 2024, when hormone replacement therapy will be freely available to those with a prescription; and if she will make a statement on the matter. [9540/25]
754. Deputy Peter 'Chap' Cleere asked the Minister for Health the reason buscopan RX has been removed from the general medical scheme/medical card scheme; and if she will make a statement on the matter. [9647/25]
778. Deputy Mary Lou McDonald asked the Minister for Health if she intends to review the terms of the drugs payment scheme; if she will extend the long-term illness scheme in order to include rheumatoid arthritis as a long-term chronic illness; and if she will make a statement on the matter. [9782/25]
372. Deputy Mairéad Farrell asked the Minister for Health if she plans to implement a regulatory framework that limits the acquisition and administration of dermal fillers to qualified doctors and dentists; and if she will make a statement on the matter. [8682/25]
391. Deputy Ryan O'Meara asked the Minister for Health the current status of efforts to licence the drug concerta, in its liquid form; and if she will make a statement on the matter. [8755/25]
411. Deputy Catherine Connolly asked the Minister for Health the timeline for implementing the proposed changes to governance and safety regulations in the field of aesthetic medicine, with specific regard to dermal fillers; and if she will make a statement on the matter. [8877/25]
295. Deputy Pádraig Rice asked the Minister for Health if a drug (details supplied) will be made available to patients with biliary tract cancers; and if she will make a statement on the matter. [8436/25]
329. Deputy Willie O'Dea asked the Minister for Health the current status of the application for approval in Ireland for palforzia as an oral immunotherapy treatment for peanut allergy; and if she will make a statement on the matter. [8538/25]